Imaging for pancreatic ductal adenocarcinoma Journal Article
| Authors: | Horvat, N.; Ryan, D. E.; LaGratta, M. D.; Shah, P. M.; Do, R. K. |
| Article Title: | Imaging for pancreatic ductal adenocarcinoma |
| Abstract: | Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide due to its aggressiveness and the challenge to early diagnosis. Complete surgical resection is the only curative option, but fewer than 20% of patients have potentially resectable disease at the time of the diagnosis. Radiologists can assess whether PDAC is resectable, borderline resectable, locally advanced or metastatic based on current imaging tests. This review will outline the role of imaging in both the diagnosis and staging of PDAC, with the goal of assisting the multidisciplinary team in tailoring the best treatment for patients. © Chinese Clinical Oncology. |
| Keywords: | review; radiation dose; cancer staging; nuclear magnetic resonance imaging; positron emission tomography; cancer diagnosis; pancreas; diagnostic imaging; ultrasound; diagnostic value; echography; pancreas adenocarcinoma; pancreatic cancer; multidetector computed tomography; computed tomography (ct); magnetic resonance imaging (mri); endoscopic ultrasonography; human; positron emission tomography-computed tomography; positron emission tomography (pet)-ct |
| Journal Title: | Chinese Clinical Oncology |
| Volume: | 6 |
| Issue: | 6 |
| ISSN: | 2304-3865 |
| Publisher: | AME Publishing Company |
| Date Published: | 2017-12-01 |
| Start Page: | 62 |
| Language: | English |
| DOI: | 10.21037/cco.2017.11.03 |
| PROVIDER: | scopus |
| PUBMED: | 29307202 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 1 February 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work